CLINICAL_TRIALS
trial_result
· 2014-06-16
Clinical Trial Update: Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal Impairment [Phase 3]
Summary
A Phase 3 trial evaluating empagliflozin in adults with type 2 diabetes and renal impairment has completed. The results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2, Renal Insufficiency | Phase 3 | Status: COMPLETED | Results posted: 2014-06-16